Page 4 - Marin Pharmaceutical Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marin pharmaceutical inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marin Pharmaceutical Inc Today - Breaking & Trending Today

BioMarin Pharmaceutical (NASDAQ:BMRN) Downgraded by Robert W. Baird

Robert W. Baird downgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) from an outperform rating to a neutral rating in a research note released on Friday morning, Marketbeat reports. The brokerage currently has $72.00 target price on the biotechnology company’s stock, down from their previous target price of $104.00. Several other brokerages have also […] ....

Jeffrey Robert Ajer , Erin Burkhart , Robertw Baird , Securities Exchange Commission , First Horizon Advisors Inc , Benjaminf Edwards Company Inc , Canaccord Genuity Group , Cantor Fitzgerald , Biomarin Pharmaceutical Company Profile , Lindbrook Capital , Jones Financial Companies Lllp , Biomarin Pharmaceutical Inc , Kb Financial Partners , Biomarin Pharmaceutical , Free Report , Genuity Group , Moderate Buy , Marin Pharmaceutical , Get Free Report , Robert Ajer , Exchange Commission , Financial Companies Lllp , First Horizon Advisors , Horizon Advisors , Marin Pharmaceutical Inc , Biomarin Pharmaceutical Daily ,

BioMarin Pharmaceutical (NASDAQ:BMRN) Coverage Initiated by Analysts at Evercore ISI

Evercore ISI began coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) in a research report report published on Tuesday, Marketbeat reports. The firm issued an outperform rating and a $113.00 price target on the biotechnology company’s stock. Several other equities research analysts have also recently issued reports on BMRN. Wells Fargo & Company […] ....

Jeffrey Robert Ajer , Erin Burkhart , Piper Sandler , Robertw Baird , Cantor Fitzgerald , Jones Financial Companies Lllp , Benjaminf Edwards Company Inc , Kb Financial Partners , First Horizon Advisors Inc , Lindbrook Capital , Biomarin Pharmaceutical Inc , Biomarin Pharmaceutical Company Profile , Wells Fargo Company , Securities Exchange Commission , Biomarin Pharmaceutical , Free Report , Moderate Buy , Marin Pharmaceutical , Get Free Report , Robert Ajer , Exchange Commission , Financial Companies Lllp , First Horizon Advisors , Horizon Advisors , Marin Pharmaceutical Inc , Biomarin Pharmaceutical Daily ,

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Sees Significant Increase in Short Interest

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) saw a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 3,910,000 shares, an increase of 6.0% from the April 15th total of 3,690,000 shares. Based on an average daily volume of 1,550,000 shares, the days-to-cover ratio […] ....

British Columbia , Piper Sandler , Erin Burkhart , Jean Jacques Bienaime , Morgan Stanley , Avoro Capital Advisors , Nan Fung Group Holdings Ltd , Biomarin Pharmaceutical Inc , Entrypoint Capital , Advisors Asset Management Inc , Biomarin Pharmaceutical , Get Free Report , Marin Pharmaceutical , Director Jean Jacques Bienaime , Capital Advisors , Pension Plan Investment Board , Fung Group Holdings Ltd , Asset Management , Marin Pharmaceutical Inc , Biomarin Pharmaceutical Daily ,

BioMarin Pharmaceutical (NASDAQ:BMRN) Receives New Coverage from Analysts at Evercore ISI

Evercore ISI initiated coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) in a research note released on Tuesday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $113.00 price objective on the biotechnology company’s stock. A number of other research analysts have also recently issued reports on BMRN. Piper Sandler […] ....

Henryj Fuchs , Robertw Baird , Erin Burkhart , Piper Sandler , First Horizon Advisors Inc , Securities Exchange Commission , Biomarin Pharmaceutical Inc , Jones Financial Companies Lllp , Kb Financial Partners , Cantor Fitzgerald , Lindbrook Capital , Morgan Stanley , Benjaminf Edwards Company Inc , Biomarin Pharmaceutical , Free Report , Marketbeat Ratings , Moderate Buy , Marin Pharmaceutical Stock Down , Marin Pharmaceutical , Get Free Report , Exchange Commission , Financial Companies Lllp , First Horizon Advisors , Horizon Advisors , Marin Pharmaceutical Inc , Biomarin Pharmaceutical Daily ,

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $107.50 Consensus PT from Analysts

Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty analysts that are covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average 1 year […] ....

George Eric Davis , Piper Sandler , Jean Jacques Bienaime , Robertw Baird , Lindbrook Capital , Benjaminf Edwards Company Inc , Jones Financial Companies Lllp , Biomarin Pharmaceutical Inc , Canaccord Genuity Group , Kb Financial Partners , First Horizon Advisors Inc , Biomarin Pharmaceutical , Get Free Report , Genuity Group , Marin Pharmaceutical , Director Jean Jacques Bienaime , Eric Davis , Financial Companies Lllp , First Horizon Advisors , Horizon Advisors , Get Free , Marin Pharmaceutical Inc , Biomarin Pharmaceutical Daily ,